Association of Baseline Body Mass Index (BMI) with Overall Survival Among Patients Over Age 60 with Acute Myeloid Leukemia (AML)

被引:0
|
作者
Brunner, Andrew M. [1 ]
Feng, Yang [2 ]
Drapkin, Benjamin J. [1 ]
Sadrzadeh, Hossein [1 ]
Ballen, Karen K. [1 ]
Attar, Eyal C. [1 ]
Amrein, Philip C. [1 ]
McAfee, Steven L. [3 ]
Neuberg, Donna S. [2 ]
Fathi, Amir T. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1182/blood.V120.21.1484.1484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1484
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Biomarkers correlating with overall survival (OS) and response to glasdegib and intensive or nonintensive chemotherapy in patients with acute myeloid leukemia (AML)
    Merchant, Akil
    Jamieson, Catriona
    Heuser, Michael
    Chan, Geoffrey
    Wang, Panpan
    Ching, Keith A.
    Johnson, Jillian
    O'Brien, Thomas
    Cortes, Jorge E.
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Association of HLA-G Haplotype Risk Model with Overall Survival In Acute Myeloid Leukemia Patients
    Volbracht, Anja
    Novotny, Juergen R.
    Ochsenfarth, Crista
    Switala, Magdalena
    Frey, Ulrich
    Horn, Peter A.
    Duehrsen, Ulrich
    Rebmann, Vera
    Nuckel, Holger
    BLOOD, 2010, 116 (21) : 895 - 895
  • [33] Association of HLA-G haplotype risk model with overall survival in acute myeloid leukemia patients
    Volbracht, A.
    Novotny, J.
    Ochsenfarth, C.
    Switala, M.
    Frey, U.
    Horn, P.
    Duehrsen, U.
    Rebmann, V
    Nueckel, H.
    ONKOLOGIE, 2010, 33 : 216 - 216
  • [34] Treatment outcomes in patients older than age 60 with acute myeloid leukemia (AML) in the nonclinical trial setting
    Duffy, Steven
    Bains, Puneet
    Pavlovitz, Brian
    Vajpayee, Neerja
    Newman, Nancy
    Gajra, Ajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Similar outcome of different treatment strategies in patients 16 to 60 years of age with acute myeloid leukemia (AML)
    Buchner, T.
    Dohner, H.
    Ehninger, G.
    Ganser, A.
    Hasford, J.
    Hehlmann, R.
    Hoelzer, D.
    Niederwieser, D.
    Pfirrmann, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)
    Acharya, Utkarsh H.
    Halpern, Anna B.
    Wu, Qian
    Voutsinas, Jenna M.
    Walter, Roland B.
    Yun, Seongseok
    Kanaan, Mohammed
    Estey, Elihu H.
    JOURNAL OF DRUG ASSESSMENT, 2018, 7 (01) : 51 - 53
  • [37] Association of body mass index (BMI) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC)
    Goswamy, Rohit Vivek
    Yildirim, Ahmet
    Choi, Yujin
    Wei, Mengting
    Liu, Yuan
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne Bernard
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Association of baseline body mass index (BMI) with overall survival (OS) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) treated with nivolumab (N) and pembrolizumab (P)
    Zhi, Jizu
    Khozin, Sean
    Kuk, Deborah
    Torres, Aracelis Z.
    Sorg, Rachael
    Lee, Shannon E.
    Miksad, Rebecca A.
    Pazdur, Richard
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] ROLE OF PERIPHERAL BLAST CLEARANCE IN SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Naqvi, K.
    Quintas-Cardama, A.
    HAEMATOLOGICA, 2012, 97 : 271 - 271
  • [40] Association between Body Mass Index and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
    Weiss, Julian J.
    Yates, Samuel J.
    Badar, Talha
    Patel, Anand Ashwin
    Winer, Eric S.
    Litzow, Mark R.
    Cheng, Wei
    Lin, Chenyu
    Shallis, Rory M.
    BLOOD, 2024, 144 : 1489 - 1490